Nektar Swings to Q1 Earnings, Updates 2015 Guidance
Nektar Therapeutics NKTR reported first-quarter 2015 earnings of 25 cents per share, as compared to the year-ago loss of 37 cents per share and the Zacks Consensus Estimate of a loss of 41 cents. The company’s bottom-line results were boosted by higher revenues. […]